Evaluating the Therapeutic Efficacy of rTMS Combined with Low-Dose Antipsychotic Medication in Somatic Symptom Disorder

rTMS combined with low-dose antipsychotic medication for SSD shows superiority over medication alone in improving anxiety and depression, enhancing quality of life, regulating neurotransmitter levels, and reducing inflammatory factors, with fewer side effects and significant clinical efficacy. However, due to the small sample size of this study, further prospective, randomized controlled studies with larger samples are needed.